(111 days)
No
The document describes a microprocessor-controlled blower-based system with standard ventilation modalities and features, and there is no mention of AI or ML in the device description, intended use, or performance studies.
Yes.
The device is intended to provide non-invasive ventilatory support to treat patients with Obstructive Sleep Apnea and Respiratory Insufficiency, directly providing therapy for medical conditions.
No
Explanation: The device is described as a ventilator providing non-invasive ventilatory support, which is a therapeutic function, not a diagnostic one. Its intended use is to treat patients, not to diagnose conditions.
No
The device description explicitly states it is a "microprocessor controlled blower based positive pressure ventilatory system with integrated heated humiditier," indicating it is a hardware device with integrated software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device provides "non-invasive ventilatory support" to treat patients with sleep apnea and respiratory insufficiency. This is a therapeutic function, not a diagnostic one.
- Device Description: The description details a "blower based positive pressure ventilatory system" that provides ventilation modalities and therapy features. This aligns with a respiratory support device, not a device used to examine specimens from the human body.
- Lack of IVD Characteristics: There is no mention of the device being used to test or analyze samples (blood, urine, tissue, etc.) from the human body to provide information for diagnosis, monitoring, or treatment.
IVD devices are specifically designed to perform tests on biological specimens to provide diagnostic information. This device's function is to provide respiratory support directly to the patient.
N/A
Intended Use / Indications for Use
The BiPAP A30 Ventilator is intended to provide non-invasive ventilatory support to treat adult and pediatric patients weighing over 10kg (22lbs) with Obstructive Sleep Apnea (OSA) and Respiratory Insufficiency. It is intended to be used in both the home and clinical settings, such as hospitals, sleep laboratories, sub-acute care institutions.
Product codes (comma separated list FDA assigned to the subject device)
MNS
Device Description
The Respironics BiPAP A30 Ventilatory Support System is a microprocessor controlled blower based positive pressure ventilatory system with integrated heated humiditier. The device platform being used as the key topic for this submission was previously cleared in K092818. The same ventilation modalities and therapy features, previously cleared in K071509 is also included in the BiPAP A30 Ventilatory Support System, which is the topic of this submission. These modes and therapy features include: CPAP, Spontaneous, Spontaneous/Timed, Pressure Control modes with Bi-Flex or AVAPS therapy features available if enabled by the health care professional. A Graphical user interface displays device data and device settings. The BiPAP A30 Ventilatory Support System is fitted with alarms to alert the user to changes that will affect the treatment. Some of the alarms are pre-set (fixed), others are user adjustable. Like its predicates, the BiPAP A30 Ventilatory Support System is intended for use with a patient circuit that is used to connect the device to the patient interface device (mask). A typical patient circuit consists of a six-foot disposable or reusable smooth lumen tubing, an exhalation device, and a patient interface device.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult and pediatric patients
Intended User / Care Setting
It is intended to be used in both the home and clinical settings, such as hospitals, sleep laboratories, sub-acute care institutions.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Design and Verification activities were performed on the BiPAP A30 as a result of the risk analysis and product design requirements. All tests confirmed the product met the predetermined acceptance criteria. Performance testing comprises pressure performance, trigger and cycling, as well as volume assured pressure support ventilation. In addition to system verification testing was performed using common protocols for BiPAP A30 and the predicate device. The side-by-side testing demonstrated that the BiPAP A30 is Substantially Equivalent to the predicate devices. Bench testing and comparative analysis has confirmed that the BiPAP A30 Ventilatory Support System performs equivalently to the cited predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
BiPAP C Series Ventilatory Support System (K092818), V60 Ventilator (K082660), ResMed Stellar 150/100 (K103167)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5895 Continuous ventilator.
(a)
Identification. A continuous ventilator (respirator) is a device intended to mechanically control or assist patient breathing by delivering a predetermined percentage of oxygen in the breathing gas. Adult, pediatric, and neonatal ventilators are included in this generic type of device.(b)
Classification. Class II (performance standards).
0
FEB - 1 2012
Addition Information Request - K113053
Philips Respironics BiPAP A30 Ventilatory Support System
Section 05: 510(k) Summary
1/3053
Administrative Information and Device Identification
| Name and address of the
manufacturer and sponsor of the
| 510(k) submission: | Manufacturer: |
|---|---|
| Respironics, Inc. | |
| 312 Alvin Drive | |
| New Kensington, PA 15068 | |
| Sponsor: | |
| Respironics | |
| 1740 Golden Mile Highway | |
| Monroeville, PA 15146 | |
| Office: 724-387-7562 | |
| Fax: 724-387-7490 | |
| FDA registration number of the | |
| manufacturer of the new device: | 2518422 |
| Official contact person for all | |
| correspondence: | Elaine Larkin |
| Regulatory Affairs Engineer | |
| Respironics | |
| 1740 Golden Mile Highway | |
| Monroeville, PA 15146 | |
| Office: 724-387-5350 | |
| Fax: 724-387-7490 | |
| Email: elaine.larkin@philips.com | |
| Submission Date | October 12, 2011 |
| Classification Reference | 21 CFR 868.5895 |
| a) Identification. A continuous ventilator (respirator) is a device intended to mechanically control or assist patient breathing by delivering a predetermined percentage of oxygen in the breathing gas. Adult, pediatric, and neonatal ventilators are included in this generic type of device. | |
| (b) Classification. Class II (performance standards). | |
| Panel Code: | MNS - ventilator, continuous, non-life |
| supporting | |
| Classification Panel: | Anesthesiology |
1
.
,
.
.
.
Philips Respironics BiPAP A30 Ventilatory
Support System
.
.
。
| Common/Usual Name | Ventilatory Support System |
|---|---|
| Proprietary name of new device: | • Respironics BiPAP A30 Ventilatory Support |
| System | |
| Predicate Device Name(s) and | |
| 510(k) numbers: | • BiPAP C Series Ventilatory Support System |
| (K092818) | |
| • V60 Ventilator | |
| (K082660) | |
| • ResMed Stellar 150/100 | |
| (K103167) | |
| Reason for submission: | Device modifications and additional accessories |
:
·
2
Philips Respironics BiPAP A30 Ventilatory Support system
Intended Use
The BiPAP A30 Ventilator is intended to provide non-invasive ventilatory support to treat adult and pediatric patients weighing over 10kg (22lbs) with Obstructive Sleep Apnea (OSA) and Respiratory Insufficiency. It is intended to be used in both the home and clinical settings, such as hospitals, sleep laboratories, sub-acute care institutions.
Device Description
The Respironics BiPAP A30 Ventilatory Support System is a microprocessor controlled blower based positive pressure ventilatory system with integrated heated humiditier. The device platform being used as the key topic for this submission was previously cleared in K092818. The same ventilation modalities and therapy features, previously cleared in K071509 is also included in the BiPAP A30 Ventilatory Support System, which is the topic of this submission. These modes and therapy features include: CPAP, Spontaneous, Spontaneous/Timed, Pressure Control modes with Bi-Flex or AVAPS therapy features available if enabled by the health care professional.
A Graphical user interface displays device data and device settings.
The BiPAP A30 Ventilatory Support System is fitted with alarms to alert the user to changes that will affect the treatment. Some of the alarms are pre-set (fixed), others are user adjustable.
Like its predicates, the BiPAP A30 Ventilatory Support System is intended for use with a patient circuit that is used to connect the device to the patient interface device (mask). A typical patient circuit consists of a six-foot disposable or reusable smooth lumen tubing, an exhalation device, and a patient interface device. ·
Performance Data
Design and Verification activities were performed on the BiPAP A30 as a result of the risk analysis and product design requirements. All tests confirmed the product met the predetermined acceptance criteria. Performance testing comprises pressure performance, trigger and cycling, as well as volume assured pressure support ventilation. In addition to system verification testing was performed using common protocols for BiPAP A30 and the predicate device. The side-by-side testing demonstrated that the BiPAP A30 is Substantially Equivalent to the predicate devices.
าใ
3
This device has been tested to appropriate ISO and IEC standards and other applicable requirements
passing all test protocols. The BIPAP A30 was designed and tested according to:
- IEC 60601-1:1988, Medical electrical equipment Part 1: General requirements for basic safety . and essential performance and its Amendments Al1:1991 and A2:1 995
- . IEC 60601-1-2:2007, Medical electrical equipment -Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests
- . EN ISO 8185 - Humidifiers for Medical Use - General Requirements for Humidification Systems
- ISO 10651-6:2004, Lung ventilators for medical use Particular requirements for basic safety and . essential performance. Part 6: Home care ventilatory support devices.
The new device complies with the applicable requirements referenced in the FDA guidance documents:
- FDA Draft Reviewer Guidance for Ventilators (July 1995) .
- FDA Guidance for the Content of Premarket Submissions for Software Contained in Medical .
- Devices (May 11, 2005) .
Non-Clinical Testing
This device has been tested to appropriate collateral and particular ISO, ASTM, and IEC standards and other applicable requirements passing all test protocols. The Respironics BiPAP A30 Ventilatory Support Systems was designed and tested according to guidance outlined in:
- FDA Draft Reviewer Guidance for Premarket Notification Submissions Anesthesiology and 1. Respiratory Devices Branch; Division of Cardiovascular, Respiratory, and Neurological Devices (November 1993);
-
- FDA Draft Reviewer Guidance for Ventilators July 1995; and
- FDA "Guidance for the Content of Premarket Submissions for Software Contained in Medical 3. Devices" (May 11, 2005).
Substantial Equivalence
The modified device has the following similarities to the previously cleared predicate devices:
- o Same intended use.
- D Same operating principle.
- 0 Same technology.
- Same manufacturing process. 0
Design verification tests were performed on the Respironics BiPAP A30 Ventilatory Support as a result of the risk analysis and product requirements. All tests were verified to meet the required acceptance criteria. Respironics has determined that the modifications have no impact on the safety
4
and effectiveness of the device. In summary, the device described in this submission is substantially equivalent to the predicate devices.
The modified device complies with the applicable standards referenced in the Guidance for FDA Reviewers and Industry "Guidance for the Content of Pre-market Submissions for Software Contained in Medical Devices," May 2006.
Conclusion:
Bench testing and comparative analysis has confirmed that the BiPAP A30 Ventilatory Support System performs equivalently to the cited predicate devices. The Respironics BiPAP A30 Ventilatory Support System is substantially equivalent to the predicate devices listed above and the device, as changed, does not raise any new issues of safety and effectiveness.
5
Image /page/5/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" written around the perimeter. In the center of the seal is an abstract symbol that resembles an eagle or bird in flight. The symbol is composed of three curved lines that form the wings and body of the bird.
Food and Drug Administration. 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Respironics, Incorporated C/O Ms. Elaine Larkin Engineer, Regulatory Affairs Sleep & Home Respiratory Group 1740 Golden Mile Highway Monroeville, Pennsylvania 15146
FEB - 1 2012
Re: K113053
Trade/Device Name: BiPAP A30 Ventilatory Support System Regulation Number: 21 CFR 868.5895 Regulation Name: Continuous Ventilator Regulatory Class: II Product Code: MNS Dated: January 23, 2012 Received: January 25, 2012
Dear Ms. Larkin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
6
Page 2 - Ms. Larkin
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Rh for
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
7
Section 4.0 Indications for Use
Indications for Use
510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________
Device Name: BiPAP A30 Ventilatory Support System
The BiPAP A30 ventilator is intended to provide non-invasive ventilatory support to treat adult and pediatric patients weighing over 10 kg (22lbs) with Obstructive Sleep Apnea (OSA and Respiratory Insufficiency. It is intended to be used in both the home and clinical settings, such as hospitals, sleep laboratories, and sub-acute care institutions.
Prescription Use _ X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
L. Schult
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: